Clinical Edge Journal Scan

Association between serum magnesium concentration and postmenopausal osteoporosis


 

Key clinical point : Postmenopausal women with osteoporosis have a lower concentration of serum magnesium (Mg). However, the association between serum Mg concentration and osteopenia is not significant.

Major finding : Serum Mg concentration was lower in postmenopausal women with osteoporosis vs. healthy controls (standardized mean difference [SMD], −0.56; 95% confidence interval [CI], −1.02 to −0.09). However, the concentration of serum Mg did not differ between those with osteopenia and healthy controls (SMD, −0.30; 95% CI, −0.69 to 0.09).

Study details : A meta-analysis of 11 studies including 2,776 postmenopausal women.

Disclosures: The study was financially supported through grants from the Natural Science Foundation of Shandong Province, the Medical and Health Science and Technology Development Project of Shandong Province, the Clinical Medical Science and Technology Innovation Program of the Jinan Science and Technology Bureau, and the Traditional Chinese Medicine Technology Development Plan of Shandong Province. The authors declared no conflicts of interest.

Source: Chang J et al. Front Med. 2020 Aug 4. doi: 10.3389/fmed.2020.00381 .

Recommended Reading

Mega vitamin D harms bone in women, not men, without osteoporosis
MDedge Rheumatology
More dairy lowers risk of falls, fractures in frail elderly
MDedge Rheumatology
Trabecular bone loss may contribute to axial spondyloarthritis progression
MDedge Rheumatology
Treat-to-target strategy ‘not ready for primetime’ in osteoporosis
MDedge Rheumatology
Longer bisphosphonate use ups AFF risk, but not all is tied to drug
MDedge Rheumatology
Reassuring rheumatic disease patients on value of bisphosphonates
MDedge Rheumatology
Asthma tied to increased risk of osteoporosis and fragility fractures
MDedge Rheumatology
Risk factors for osteosarcopenia in postmenopausal women with osteoporosis
MDedge Rheumatology
Pro-inflammatory diets tied to osteoporosis risk
MDedge Rheumatology
Postmenopausal osteoporosis: Factors influencing early treatment with romosozumab
MDedge Rheumatology